Clearside BioMedical
Manufacturing · Georgia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
900 N Point Pkwy Ste 200, Alpharetta, Ge...Phone Number
(678) 270-3631Website
clearsidebio.comRevenue
<$5 MillionStock Symbol
CLSDIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
3
1
1
1
1
About Clearside BioMedical
Clearside Biomedical, Inc. is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. SCS Microinjector® enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.Explore more
Clearside BioMedical Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Clearside BioMedical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Clearside BioMedical
Click to see if Clearside BioMedical had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Clearside BioMedical has new funding data
Clearside BioMedical, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Clearside BioMedical recently announced quarterly report
Product Launch: Get notified when Clearside BioMedical launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Clearside BioMedical has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Clearside BioMedical is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Clearside BioMedical
Compare insights from companies similar to Clearside BioMedical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Clearside BioMedical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Clearside BioMedical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Clearside BioMedical.
Clearside BioMedical financials insights
Gather financial insights about Clearside BioMedical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Series A
$4M
2013
Other Financing Round
$7.9M
2014
Unspecified
$6M
Series B
$16M
2015
Series C
$20M
2016
Stock Offering
$50.4M
2020
Debt
$350K
Clearside BioMedical Tech Stack
A closer look at the technologies used by Clearside BioMedical
See more technologies
Most Recent Scoops
Pain Point
Pain Point, Bankruptcy, Finance
Project
, according to a mid-level source in MED, is in the midst of initiatives related to healthcare collaboration software.
Collaboration/Web Apps, Employee Relations, Software, Unified Communications, Healthcare Technology
Project
, according to a mid-level source in MED, has completed initiatives related to patient data within the last twelve months.
Clinical Systems, Data Management, Information Governance, Patient Experience
Project
, according to a mid-level source in MED, has completed initiatives related to value-based care models within the last twelve months.
Quality Management, Healthcare Operations, Patient Experience
Project
Quality Management
Clearside BioMedical News & Media
Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
- Intended to Maximize Stakeholder Value Through Structured Process -Clearside Biomedical, Inc. (NASDAQ:CLSD) Receives Average Recommendation of “Hold ...
Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Free Report) has earned a consensus recommendation of “Hold” from the six analysts that are currently covering the stock, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 1-year price objective […]Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress
- Presentations Highlight the Versatility of Clearside’s SCS Microinjector® Platform for the Treatment of Multiple Retinal Diseases -Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada
- XIPERE Now Approved for Use in Multiple Global Markets -
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Clearside BioMedical
Sign Up For FreeTo access detailed company insights
Clearside Biomedical, Inc. is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. SCS Microinjector® enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to p... Read More
